Delek US (DK) Rule 144 sale notice: 28,494 shares on 11/11/2025

Delek US Holdings (DK) filed a Form 144 indicating a proposed sale of 28,494 common shares.

Rhea-AI Filing Summary

Delek US Holdings (DK) filed a Form 144 indicating a proposed sale of 28,494 common shares. The filing lists an approximate sale date of 11/11/2025, an aggregate market value of $1,166,605.81, and identifies Merrill Lynch as broker, with trading on the NYSE.

The shares were acquired through the vesting of stock awards on multiple dates between 12/09/2023 and 11/11/2025, as shown in the acquisition table. This notice outlines an intention to sell under Rule 144 and includes the required representation regarding knowledge of material nonpublic information.

Insights

Capital markets counsel

Routine Rule 144 sale notice; limited market impact.

This is a standard Form 144 indicating an intended sale of restricted/controlled securities. The filing lists 28,494 shares, an $1,166,605.81 aggregate market value, and an approximate sale date of 11/11/2025. It specifies Merrill Lynch as broker and the NYSE as the exchange.

The shares were acquired via vesting of stock awards across multiple dates in 2023–2025. Rule 144 filings are administrative and do not, by themselves, mandate a sale or set pricing; actual sales depend on market conditions and seller decisions. Overall, this is neutral in isolation.

FAQ

What did Delek US (DK) file under Rule 144?

A notice of proposed sale covering 28,494 common shares with an aggregate market value of $1,166,605.81.

When is the approximate sale date for the DK shares?

The filing lists an approximate sale date of 11/11/2025.

Which broker and exchange are listed for the DK sale?

The broker is Merrill Lynch, and the shares are listed for sale on the NYSE.

How were the DK shares to be sold acquired?

They were acquired through the vesting of stock awards on multiple dates between 12/09/2023 and 11/11/2025.

Does the DK Form 144 guarantee that the sale will occur?

No. It is a notice of intent under Rule 144; actual sales depend on market conditions and the holder’s decisions.

What is the total number of DK shares listed as to be sold?

The filing lists 28,494 shares of common stock.

What is the aggregate market value tied to the proposed DK sale?

The filing states an aggregate market value of $1,166,605.81.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 04:56 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001333478
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Delek US Holdings Inc.
SEC File Number	001-38142
Address of Issuer	310 Seven Springs Way Suite 500 Brentwood TENNESSEE 37027
Phone	6157716701
Name of Person for Whose Account the Securities are To Be Sold	Joseph Israel
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3455 Peachtree Road NE Suite 1000 Atlanta GA 30326	28494	1166605.81	60051553	11/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/09/2023	Vesting of a Stock Award	Delek US Holdings Inc.			1355	12/09/2023	Compensatory Payment
Common	03/09/2024	Vesting of a Stock Award	Delek US Holdings Inc.			640	03/09/2024	Compensatory Payment
Common	06/09/2024	Vesting of a Stock Award	Delek US Holdings Inc.			677	06/09/2024	Compensatory Payment
Common	09/09/2024	Vesting of a Stock Award	Delek US Holdings Inc.			677	09/09/2024	Compensatory Payment
Common	09/10/2024	Vesting of a Stock Award	Delek US Holdings Inc.			1189	09/10/2024	Compensatory Payment
Common	12/09/2024	Vesting of a Stock Award	Delek US Holdings Inc.			677	12/09/2024	Compensatory Payment
Common	12/10/2024	Vesting of a Stock Award	Delek US Holdings Inc.			476	12/10/2024	Compensatory Payment
Common	03/09/2025	Vesting of a Stock Award	Delek US Holdings Inc.			564	03/09/2025	Compensatory Payment
Common	03/10/2025	Vesting of a Stock Award	Delek US Holdings Inc.			495	03/10/2025	Compensatory Payment
Common	05/11/2025	Vesting of a Stock Award	Delek US Holdings Inc.			8173	05/11/2025	Compensatory Payment
Common	06/09/2025	Vesting of a Stock Award	Delek US Holdings Inc.			543	06/09/2025	Compensatory Payment
Common	06/10/2025	Vesting of a Stock Award	Delek US Holdings Inc.			476	06/10/2025	Compensatory Payment
Common	08/11/2025	Vesting of a Stock Award	Delek US Holdings Inc.			4086	08/11/2025	Compensatory Payment
Common	09/09/2025	Vesting of a Stock Award	Delek US Holdings Inc.			543	09/09/2025	Compensatory Payment
Common	09/10/2025	Vesting of a Stock Award	Delek US Holdings Inc.			3837	09/10/2025	Compensatory Payment
Common	11/11/2025	Vesting of a Stock Award	Delek US Holdings Inc.			4086	11/11/2025	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joseph Israel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)